Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Palatin Technologies Inc (NYSE MKT LLC:PTN)

0.415
Delayed Data
As of 2:29pm ET
 -0.0261 / -5.92%
Today’s Change
0.36
Today|||52-Week Range
0.90
-17.84%
Year-to-Date
AMAG, Palatin Ink Deal to Focus on Female Sexual Disorder
Jan 10 / Zacks.com - Paid Partner Content
Why AMAG Pharmaceuticals, Inc. Is Falling Today
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.44
Today’s open0.46
Day’s range0.40 - 0.46
Volume4,576,496
Average volume (3 months)2,719,819
Market cap$58.9M
Dividend yield--
Data as of 2:29pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-120.00%
Earnings growth (this year)+12.12%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTECIntec Pharma Ltd+0.10+1.92%
LIFEaTyr Pharma Inc-0.02-1.00%
OVASOvaScience Inc+0.03+1.84%
JNPJuniper Pharmaceutic...-0.11-2.06%
Data as of 2:40pm ET, 01/17/2017

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$51.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Carl Spana
COO, CFO, Secretary, Treasurer &
Executive VP
Stephen T. Wills
Corporate headquarters
Cranbury, New Jersey

Forecasts


Search for Jobs